Access cutting-edge non-alcoholic fatty liver disease treatment through this clinical trial at a research site in Edinburg. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Edinburg location
Access non-alcoholic fatty liver disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-alcoholic fatty liver disease treatment provided free
Check if you qualify for this non-alcoholic fatty liver disease clinical trial in Edinburg, TX
No-Cost Study Care
Local to Edinburg
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The design of the Phase 2 clinical trial includes the following elements: * Multi-center, two-arm, randomized, double-blind, placebo-controlled trial to evaluate MN-001 (tipelukast) vs. placebo in approximately 40 patients in the U.S. * Patients will be randomized 1:1 to receive either 500 mg/day of MN-001 (tipelukast) or placebo for 24 weeks. * The co-primary endpoints are (1) change from baseline in liver fat content measured by controlled attenuation parameter (CAP) score at Week 24, and (2)
Sponsor: MediciNova
Yes, this clinical trial (NCT05464784) has an active research site in Edinburg, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for non-alcoholic fatty liver disease treatment options in Edinburg, TX, this clinical trial (NCT05464784) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Edinburg research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-alcoholic fatty liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all non-alcoholic fatty liver disease clinical trials near you to find additional studies recruiting in your area.
See all ankylosing spondylitis clinical trials recruiting in Edinburg — not just this study.
Browse Ankylosing Spondylitis Trials in Edinburg →